ghk-cu tachyphylaxis or tolerance or desensitization Understanding and in Pharmacology | Priyanshu Raj posted on the topic GLP3 Peptide | USA Made
Description
Some protocols move toward 0.5 mg per day under close medical supervision if a provider determines a higher dose is appropriate for a specific patient

The practical sequencing rule: use LED before microinfusion or wait 24 hours after

Temperature proves critical

Scott Brunner of the Alliance for Pharmacy Compounding has described this as the start of a "protracted process." Even under the most optimistic scenario, broad clinical availability of legally compounded versions of these peptides is likely a mid-to-late 2026 proposition at the earliest and possibly longer if the political or regulatory environment shifts
